Cargando…

Effects of SNF472, a Novel Inhibitor of Hydroxyapatite Crystallization in Patients Receiving Hemodialysis — Subgroup Analyses of the CALIPSO Trial

INTRODUCTION: Coronary artery calcium (CAC) is highly prevalent and linked with poor outcomes in patients receiving maintenance hemodialysis, and its reduction may improve patient prognosis. SNF472, a selective inhibitor of hydroxyapatite crystallization, slows CAC progression in patients receiving...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raggi, Paolo, Bellasi, Antonio, Sinha, Smeeta, Bover, Jordi, Rodriguez, Mariano, Ketteler, Markus, Bushinsky, David A., Garg, Rekha, Perelló, Joan, Gold, Alex, Chertow, Glenn M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710828/ https://www.ncbi.nlm.nih.gov/pubmed/33305110 http://dx.doi.org/10.1016/j.ekir.2020.09.032

Ejemplares similares

Trial design and baseline characteristics of CaLIPSO: a randomized, double-blind placebo-controlled trial of SNF472 in patients receiving haemodialysis with cardiovascular calcification
por: Bellasi, Antonio, et al.
Publicado: (2019)

The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis
por: Sinha, Smeeta, et al.
Publicado: (2021)

Characterization of SNF472 pharmacokinetics and efficacy in uremic and non-uremic rats models of cardiovascular calcification
por: Ferrer, Miguel D., et al.
Publicado: (2018)

SNF472, a novel inhibitor of vascular calcification, could be administered during hemodialysis to attain potentially therapeutic phytate levels
por: Perelló, Joan, et al.
Publicado: (2018)

Lateral Boundary of Cirrus Cloud from CALIPSO Observations
por: Fu, Yunfei, et al.
Publicado: (2017)

Psoriasis severity and hypothalamic-pituitary-adrenal axis function: results from the CALIPSO study
por: Brunoni, A.R., et al.
Publicado: (2014)

CALIPSO lidar level 3 aerosol profile product: version 3 algorithm design
por: Tackett, Jason L., et al.
Publicado: (2018)

Etelcalcetide Is Effective at All Levels of Severity of Secondary Hyperparathyroidism in Hemodialysis Patients
por: Cunningham, John, et al.
Publicado: (2019)

Comparison of AOD from CALIPSO, MODIS, and Sun Photometer under Different Conditions over Central China
por: Liu, Boming, et al.
Publicado: (2018)

Assessment of the GOES-16 Clear Sky Mask Product over the Contiguous USA Using CALIPSO Retrievals
por: Jiménez, Pedro A.
Publicado: (2020)

472 Indiana CTSI Think Tank Program
por: Garcia, Kara, et al.
Publicado: (2022)

One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism
por: Bushinsky, David A, et al.
Publicado: (2019)

One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism
por: Bushinsky, David A, et al.
Publicado: (2019)

Traumatic Hyphaema: A report of 472 consecutive cases
por: Ashaye, Adeyinka O
Publicado: (2008)

472 Ceftaroline-induced Neutropenia: Two Case Reports
por: Martin, Kelly E., et al.
Publicado: (2014)

472. Rethinking the Role of Clindamycin for Toxin-Mediated Illnesses
por: Saldarriaga Perez, Carolina, et al.
Publicado: (2019)

CALIPSO IIR Version 2 Level 1b calibrated radiances: analysis and reduction of residual biases in the Northern Hemisphere
por: Garnier, Anne, et al.
Publicado: (2018)

Lessons for Medicare Part D in the hemodialysis community
por: Nayeem, Anisa I, et al.
Publicado: (2006)

Multi-omic alterations of the SWI/SNF complex define a clinical subgroup in lung adenocarcinoma
por: Peinado, Paola, et al.
Publicado: (2022)

MED40/472: A WWW Multimedia Textbook of Internal Propedeutics
por: Zelenková, J, et al.
Publicado: (1999)

472. The Utility of Infectious Diseases E-consults in the Era of COVID-19
por: Saad, Hala, et al.
Publicado: (2020)

Targeting Vascular Calcification in Chronic Kidney Disease
por: Nelson, Adam J., et al.
Publicado: (2020)

Correction: Naudts, J. Quantum Statistical Manifolds. Entropy 2018, 20, 472
por: Naudts, Jan
Publicado: (2018)

472. The impact of sarcopenia on unfavorable outcomes in lung transplant patients with COVID-19
por: Han, Min, et al.
Publicado: (2023)

Whole-genome resequencing of 472 Vitis accessions for grapevine diversity and demographic history analyses
por: Liang, Zhenchang, et al.
Publicado: (2019)

SAT-472 Increased Thyroid Cancer Risk in Acromegaly: A Report of 3 Cases
por: Jaisinghani, Priya, et al.
Publicado: (2019)

Binding Studies of the Prodrug HAO472 to SARS-Cov-2 Nsp9 and Variants
por: Liu, Miaomiao, et al.
Publicado: (2022)

Treatment of secondary hyperparathyroidism in non-dialysis CKD: an appraisal 2022s
por: Ketteler, Markus, et al.
Publicado: (2022)

SNF TO HOME: OUTCOMES OF THE SNF RE-ENGINEERED (RED) DISCHARGE PROCESS
por: Popejoy, Lori L, et al.
Publicado: (2019)

The Effect of Frequent Hemodialysis on Nutrition and Body Composition: Frequent Hemodialysis Network Trial
por: Kaysen, George A., et al.
Publicado: (2012)

Cardiovascular Biomarkers in Chronic Kidney Disease: State of Current Research and Clinical Applicability
por: D'Marco, Luis, et al.
Publicado: (2015)

Safety and efficacy of the Tablo hemodialysis system for in‐center and home hemodialysis
por: Plumb, Troy J., et al.
Publicado: (2019)

472. Prevalence, Risk Factors, and Outcome of Postoperative Clostridium difficile Infection After Orthopedic Surgery
por: Kim, Dong Youn, et al.
Publicado: (2018)

Prevalence of Pediatric and Adolescent Balance Disorders: Analysis of a Mono-Institutional Series of 472 Patients
por: Balzanelli, Cristiano, et al.
Publicado: (2021)

SAT472 A Case of Contrast Induced Thyrotoxicosis in a Patient Newly Diagnosed with Hyperthyroidism
por: Askar, Esraa, et al.
Publicado: (2023)

Sarcopenia among patients receiving hemodialysis: weighing the evidence
por: Kittiskulnam, Piyawan, et al.
Publicado: (2016)

Patient‐reported outcomes from the investigational device exemption study of the Tablo hemodialysis system
por: Chertow, Glenn M., et al.
Publicado: (2020)

Disparities in the Timing of Preoperative Hemodialysis Among Patients With End-Stage Kidney Disease
por: Fielding-Singh, Vikram, et al.
Publicado: (2023)

Personalized Prediction of Short- and Long-Term PTH Changes in Maintenance Hemodialysis Patients
por: Pirklbauer, Markus, et al.
Publicado: (2021)

Proteins Structure Models in the Evaluation of Novel Variant (C.472_477del) in the MOCS2 Gene
por: Jezela-Stanek, Aleksandra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qjfgsbj6vo56ejc0c0lpg2cvdu